Company Filing History:
Years Active: 2013
Title: Siobhan Roche: Innovator in the p21 Pathway Modulation
Introduction
Siobhan Roche is a notable inventor based in Coolock, Ireland. She has made significant contributions to the field of biotechnology, particularly in understanding the p21 pathway and its implications for various disorders. Her work has the potential to pave the way for new therapeutic strategies.
Latest Patents
Siobhan Roche holds a patent titled "RORS as modifiers of the p21 pathway and methods of use." This patent identifies human ROR genes as modulators of the p21 pathway, highlighting their role as therapeutic targets for disorders associated with defective p21 function. The patent also provides methods for identifying modulators of p21, which include screening for agents that can modulate the activity of ROR.
Career Highlights
Siobhan Roche is currently employed at Exelixis, Inc., where she continues to advance her research in the field. Her innovative work has garnered attention and recognition within the scientific community.
Collaborations
Some of her notable coworkers include Helen Louise Francis-Lang and Lori Friedman. Their collaborative efforts contribute to the ongoing research and development in the area of p21 pathway modulation.
Conclusion
Siobhan Roche's contributions to the understanding of the p21 pathway and her innovative patent work position her as a key figure in biotechnology. Her research holds promise for developing new therapeutic approaches for disorders linked to p21 dysfunction.